Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Keywords: (Dab)-1; Alzheimer's disease; Amyloid; Apolipoprotein E receptors type-2; Dab2; FXNPXY sequences; IGF; LDL-R-related protein 1; LRP-1; LRP-2; MCTF; Notch; Regulated Intramembrane Proteolysis; amyloidosis; apical surface; arachnoid epithelium; astrocytes; autosomal recessive hypercholesterolemia; blood-CSF barrier; blood-brain barrier; c-Jun N-terminal kinase -interacting protein; cerebrovascular endothelial cells; choroid plexus epithelial cells; choroid plexus epithelium; cingulin; clathrin-coated pits; claudins; clearance; disabled homolog; drug delivery; intracellular domain; kinase scaffold proteins; megalin; membrane-associated C-terminal fragment; metallo-proteinase; milieu; mitogen-activating protein; occludins; p75NTR signalling pathway; pericytes; pino-cytic vesicles; presenilin 1; regulated intramembrane proteolysis; semaphorin-binding protein-1; synaptic density protein-95; transthyretin; very low-density lipoprotein receptor
Document Type: Research Article
Publication date: 01 November 2010
- Recent Patents on Endocrine, Metabolic & Immune Drug Discovery publishes review articles by experts on recent patents in the field of endocrine, metabolic and immune drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery.
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content